Cargando…
Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever
Severe bacterial infections (SBI) have become less frequent in children with sickle cell disease (SCD) in the last decades. However, because of their potential risk of SBI, they usually receive empirical therapy with broad-spectrum antibiotics when they develop fever and are hospitalized in many cas...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484827/ https://www.ncbi.nlm.nih.gov/pubmed/34596837 http://dx.doi.org/10.1007/s15010-021-01702-w |
_version_ | 1784577403367981056 |
---|---|
author | Rincón-López, Elena María Navarro Gómez, María Luisa Hernández-Sampelayo Matos, Teresa Aguilera-Alonso, David Dueñas Moreno, Eva Bellón Cano, José María Saavedra-Lozano, Jesús del Mar Santos Sebastián, María García Morín, Marina Beléndez Bieler, Cristina Lorente Romero, Jorge Cela de Julián, Elena |
author_facet | Rincón-López, Elena María Navarro Gómez, María Luisa Hernández-Sampelayo Matos, Teresa Aguilera-Alonso, David Dueñas Moreno, Eva Bellón Cano, José María Saavedra-Lozano, Jesús del Mar Santos Sebastián, María García Morín, Marina Beléndez Bieler, Cristina Lorente Romero, Jorge Cela de Julián, Elena |
author_sort | Rincón-López, Elena María |
collection | PubMed |
description | Severe bacterial infections (SBI) have become less frequent in children with sickle cell disease (SCD) in the last decades. However, because of their potential risk of SBI, they usually receive empirical therapy with broad-spectrum antibiotics when they develop fever and are hospitalized in many cases. We performed a prospective study including 79 SCD patients with fever [median age 4.1 (1.7–7.5) years, 78.5% males; 17 of the episodes were diagnosed with SBI and 4 of them were confirmed] and developed a risk score for the prediction of SBI. The optimal score included CRP > 3 mg/dl, IL-6 > 125 pg/ml and hypoxemia, with an AUC of 0.91 (0.83–0.96) for the prediction of confirmed SBI and 0.86 (0.77–0.93) for possible SBI. We classified the patients in 3 groups: low, intermediate and high risk of SBI. Our risk-score-based management proposal could help to safely minimize antibiotic treatments and hospital admissions in children with SCD at low risk of SBI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01702-w. |
format | Online Article Text |
id | pubmed-8484827 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84848272021-10-01 Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever Rincón-López, Elena María Navarro Gómez, María Luisa Hernández-Sampelayo Matos, Teresa Aguilera-Alonso, David Dueñas Moreno, Eva Bellón Cano, José María Saavedra-Lozano, Jesús del Mar Santos Sebastián, María García Morín, Marina Beléndez Bieler, Cristina Lorente Romero, Jorge Cela de Julián, Elena Infection Brief Report Severe bacterial infections (SBI) have become less frequent in children with sickle cell disease (SCD) in the last decades. However, because of their potential risk of SBI, they usually receive empirical therapy with broad-spectrum antibiotics when they develop fever and are hospitalized in many cases. We performed a prospective study including 79 SCD patients with fever [median age 4.1 (1.7–7.5) years, 78.5% males; 17 of the episodes were diagnosed with SBI and 4 of them were confirmed] and developed a risk score for the prediction of SBI. The optimal score included CRP > 3 mg/dl, IL-6 > 125 pg/ml and hypoxemia, with an AUC of 0.91 (0.83–0.96) for the prediction of confirmed SBI and 0.86 (0.77–0.93) for possible SBI. We classified the patients in 3 groups: low, intermediate and high risk of SBI. Our risk-score-based management proposal could help to safely minimize antibiotic treatments and hospital admissions in children with SCD at low risk of SBI. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s15010-021-01702-w. Springer Berlin Heidelberg 2021-10-01 2022 /pmc/articles/PMC8484827/ /pubmed/34596837 http://dx.doi.org/10.1007/s15010-021-01702-w Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Brief Report Rincón-López, Elena María Navarro Gómez, María Luisa Hernández-Sampelayo Matos, Teresa Aguilera-Alonso, David Dueñas Moreno, Eva Bellón Cano, José María Saavedra-Lozano, Jesús del Mar Santos Sebastián, María García Morín, Marina Beléndez Bieler, Cristina Lorente Romero, Jorge Cela de Julián, Elena Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title | Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title_full | Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title_fullStr | Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title_full_unstemmed | Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title_short | Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
title_sort | risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484827/ https://www.ncbi.nlm.nih.gov/pubmed/34596837 http://dx.doi.org/10.1007/s15010-021-01702-w |
work_keys_str_mv | AT rinconlopezelenamaria riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT navarrogomezmarialuisa riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT hernandezsampelayomatosteresa riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT aguileraalonsodavid riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT duenasmorenoeva riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT belloncanojosemaria riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT saavedralozanojesus riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT delmarsantossebastianmaria riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT garciamorinmarina riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT belendezbielercristina riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT lorenteromerojorge riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT celadejulianelena riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever AT riskscorebasedstrategytominimizeantibioticexposureinchildrenwithsicklecelldiseaseandfever |